The disclosure relates to intravascular catheters having a purge system, and optionally, a guidewire lumen through an impeller.
Congestive heart failure is the result of a weakened heart. As blood flow out of the heart slows, blood returning to the heart backs up and increases in pressure in the veins, inhibiting drainage from the lymphatic system, causing congestion in the body, resulting in edema. Edema may manifest as visible swelling in a person's legs and ankles, and can be present in other parts of the body as well. Sometimes fluid collects in the lungs and interferes with breathing. This is called pulmonary edema and can be particularly distressing. Heart failure also affects the ability of the kidneys to dispose of sodium and water and the retained water also contributes to the edema.
Congestive heart failure and edema may potentially be treated using drugs or medical devices. For example, intravascular catheters may potentially be used to assist in draining the lymphatic system or pumping blood. Such catheters may be designed with mechanical components such as pumps or inflatable balloons.
Intravascular treatment using catheters with mechanical components presents a variety of challenges. For example, intravascular catheters having mechanical parts typically have joints or different connection points that couple different mechanical elements of the catheter. Those joints or connection points serve as locations where body fluid, e.g., blood and/or lymph, can enter or leak into the catheter. Blood and lymph contain live cells, dead cells, fragments of lipids, free nucleic acids, and other materials. Those materials can interfere with the reliable functioning of an intravascular device, particularly operation of rotating mechanical parts. Additionally, the body fluid that enters the catheter could possibly travel to a proximal portion of the catheter outside of the patient's body, where it could leak out of the catheter, creating an unsterile situation for the patient and care providers.
The disclosure provides intravascular catheters having mechanical components, e.g., an impeller and/or drive shaft, and a purge system. The purge system operates to exclude biological fluids and materials from the catheter and mechanical components operating within the catheter. In that manner, the intravascular catheters of the invention are able to prevent body fluid from entering the catheter, ensuring smooth and efficient operation of the mechanical parts, e.g., impeller and drive shaft, within the catheter while also preventing the patient's body fluid from travelling to a proximal portion of the catheter outside of the patient's body, where it could leak out of the catheter.
In certain aspects, a distal portion of a catheter can be dimensioned for insertion into a blood vessel. The catheter can be equipped with an impeller coupled to a rotating drive shaft. As will be discussed below, the catheter can have additional features to restrict flow or to aid flow, such as inflatable balloons or pumps. The catheter is also equipped with a purge system that can use, for example, a purge fluid to prevent blood, lymph, or other biological materials from entering mechanical parts of the catheter, e.g., motor, impeller, driver shaft, etc. The purge system of the disclosure excludes bodily fluids from the catheter both while the devices are not deployed or not operating and while such devices are deployed or operating. For example, the catheter can be purged by a purge fluid under hydrostatic pressure that excludes bodily fluid while a physician is navigating the catheter to the desired location. In embodiments in which the catheter includes a device such as an impeller, centrifugal force can be exploited to wash the impeller and associated motor during operation of the device.
In certain embodiments, the device includes a catheter dimensioned for insertion into a bodily lumen, a porous drive shaft extending from a motor and through the catheter, in which a portion of the drive shaft is housed within a tube comprising one or more through holes, and an infusion channel in fluid communication with the porous drive shaft and arranged such that purge fluid is discharged through the porous drive shaft and through the through holes of the tube. A proximal end of the tube includes a proximal sealed connection around the drive shaft. Operation of the motor rotates the drive shaft within the tube. A distal end of the tube may include a distal sealed connection around the drive shaft. The device may further include one or more inflatable balloons disposed along the catheter, each in fluid communication with an inflation lumen extending along the catheter.
When the motor is not rotating, a static pressure of the purge fluid prevents bodily fluid from entering the housing. When the motor is rotating, the purge fluid is subject to centrifugal force along the drive shaft preventing bodily fluid from approaching the proximal portion of the catheter. The motor may include a rotor disposed within a stator in a housing at a proximal portion of the catheter. The porous drive shaft may be coupled to, and extending from, the rotor.
Preferably, when the impeller is inserted into vasculature of a patient, the proximal sealed connection, the tube, and/or the distal sealed connection separate the purge fluid within the porous drive shaft from blood within the catheter outside of the tube.
In some embodiments, the impeller has one or more blades disposed along an impeller shaft coupled to the drive shaft, in which the impeller shaft has an impeller shaft lumen therethrough and one or more holes along a side of the impeller shaft such that rotation of the impeller in a liquid subjects the liquid to centrifugal force at the one or more holes. When rotating, the purge fluid is driven by centrifugal force outward through the through-holes along the impeller shaft such that the purge fluid continually washes the impeller. In certain embodiments, when the impeller is disposed within vasculature of a patient and the motor is operated, the impeller pumps blood and the purge fluid rinses at least a portion of the impeller.
The disclosure additionally provides intravascular catheters with treatment devices such as impellers that can be delivered over, and operated over, a guidewire, to aid in operating intravascular treatment devices in the correct location and orientation within a body. That is, in certain aspects, the invention provides intravascular impeller based devices in which the impeller has a guidewire channel there through and the impeller can operate while a guidewire is extended through the impeller within the guidewire channel. As discussed herein, catheters of the disclosure may include additional features that operate to restrict flow, to assist flow, or both. A physician can navigate a guidewire to an intended treatment location and manually refine the positioning of the guidewire. The device is loaded onto the guidewire via the guidewire channel that passes through the impeller. The device is then pushed over the guidewire to the intended location. Exemplary embodiments include a catheter with one or more flow restrictors, such as inflatable balloons, and a pump or impeller, in which the flow restrictors create a low pressure zone around an output of a thoracic duct while the impeller aids in draining the lymphatic system. The inflatable balloons and the impeller can be deployed and operated, respectively, even while the guidewire extends through a guidewire lumen that passes through the impeller.
By including over-the-wire treatment devices on an intravascular catheter, in which those devices can be deployed and operated while the catheter is being navigated over a guidewire, the disclosure provides intravascular treatment devices that can be delivered to, and oriented correctly at, a desired location within a patient. The guidewire functionality assists greatly in properly positioning the treatment devices.
Aspects of the invention provide a device that includes an impeller dimensioned for insertion into vasculature of a patient, a guidewire lumen extending through the impeller, and a drive mechanism operable to rotate the impeller while the impeller is in the vasculature with a guidewire extending through the lumen. The drive mechanism may include a hollow driveshaft extending proximally from the impeller to a motor. The hollow driveshaft may extend through a catheter having a proximal portion and a distal portion, in which the impeller is distal to the distal portion and the motor is proximal to the proximal portion. In some embodiments, the motor sits in a housing connected to the proximal portion of the catheter. The motor may include a stator housed within the housing and a rotor disposed within the stator, wherein the guidewire lumen extends through the impeller, through the driveshaft, and through the rotor.
In certain embodiments, the guidewire lumen opens to a tapered port at a proximal portion of the housing. The device may include a hollow atraumatic tip extending distally from the impeller.
In some embodiments, the hollow driveshaft extends through an extended catheter, in which the impeller is disposed at a distal portion of the catheter and the motor is disposed at a proximal portion of the catheter. The device may include an impeller housing connected to the distal portion of the catheter and may include at least one inlet port proximal to the impeller and at least one outlet port distal to the impeller, wherein rotation of the impeller impels liquid through the impeller housing. The device may further include an expandable member on the distal portion of the catheter and at least one inflation lumen extending through the catheter.
In some embodiments, the expandable member comprises a substantially toroidal balloon connected to the catheter or impeller housing by an expandable membrane. When the catheter is inserted over a guidewire into the vasculature, the balloon can be inflated and the impeller can be rotated by operation of the motor while the guidewire extends through the device.
By including a purge system, devices of the catheter operate reliably and operation of those device is not interfered with by cells, dead cell fragments and other debris found in bodily fluids. Thus intravascular catheters of the disclosure are easily positioned and operate reliably. The catheters may include treatment devices that are particularly suited to the treatment of edema or congestive heart failure, such as mechanisms that aid in draining a lymphatic system. Since the guidewire aids in positioning the device, and the purge system facilitates reliable operation, intravascular catheters of the disclosure may be used to treat heart failure and edema with positional accuracy and material reliability.
In certain embodiments, the impeller and the drive shaft may define or include a guidewire lumen that extends through the impeller and the drive shaft. The guidewire lumen preferably extends through the motor, such that when the device is inserted into vasculature of a patient over a guidewire, operation of the motor rotates the impeller within the vasculature while the guidewire extends through the guidewire lumen. The device may be operable when the guidewire extends distally out of a distal tip of device. In such embodiments, when the device is inserted into the vasculature of the patient over the guidewire: the purge fluid continually purges the catheter when the motor is operated; and the purge fluid continually purges the catheter when the motor is not operated.
Preferably, when the impeller is inserted into vasculature of a patient, the purge fluid purges the catheter by hydrostatic pressure while the motor is not operated and the purge fluid purges the catheter by centrifugal force while the motor is operated.
In related aspects, the invention provides a device having an impeller disposed at a distal portion of a catheter and dimensioned for insertion into vasculature of a patient. When the impeller is inserted into the vasculature of a patient, a purge fluid purges the catheter by hydrostatic pressure while the impeller is not being rotated and the purge fluid purges the catheter by centrifugal force while the impeller is being rotated.
An infusion channel 123 enters the housing 105, allowing a purge fluid 125 to enter the catheter by the infusion channel 123. As discussed in greater detail below, the device 101 may include one or more expandable members 163, e.g., located at the distal portion 108 of the catheter 107.
The device 101 includes a porous drive shaft 111 extending from a motor 113 through the catheter 107. A portion of the drive shaft 111 is housed within a tube 119 that may extend from the housing 105 to the distal portion 108.
At the housing 105, an infusion channel 123 is in fluid communication with the porous drive shaft 111 and arranged such that a purge fluid 125 is discharged through the porous drive shaft 111 and towards the distal portion 108.
The distal portion 108 includes the distal end 120 of the tube 119, with an expandable membrane 168 and balloon 164 disposed about the catheter. Distal to the distal end 120 of the tube 119 is an impeller housing 144, housing an impeller 143, and a hollow atraumatic tip 180. The balloon 164 (when inflated), the expandable membrane 168 (which expands when the balloon 164 is inflated), and the impeller housing 144 collectively provide and include at least one inlet port 129 and outlet port 130, which provide a passage through the membrane 168 and impeller housing 144 through which the impeller 143 can pump a fluid such as blood.
The tube 119 extends from a proximal end 118 of the tube 119 (in the housing 105) to a distal end of 120 of the tube 119 (on the distal portion 108 of the catheter 107). The tube 119 surrounds a length of the hollow driveshaft 111 extending from the drive mechanism 130. Specifically, the hollow driveshaft 111 extends from the rotor 127 mounted within the stator 131.
The distal portion 108 includes the impeller 143, dimensioned for insertion into vasculature of a patient. A guidewire lumen 175 extends through the impeller 143. The drive mechanism 130 is operable to rotate the impeller 143 while the impeller 143 is in the vasculature with a guidewire extending through the guidewire lumen 175. Features and devices of the invention may be used in a variety of catheters and treatment devices and may, for example, be incorporated into any of those devices described in U.S. Pat. No. 9,901,722; U.S. Pub. 2016/0331378; U.S. Pub. 2015/0343186; U.S. Pub. 2015-0343136; U.S. Pub. 2017/0197021; Int'l Patent Appl. Pub. WO 2016/181217; Intl Patent Appl. Pub. WO 2015/186005; and Int'l Patent Appl. Pub. WO 2015/186003, the contents of each of which are incorporated by reference.
With reference back to
Components described herein thus provide a purge system for an intravascular treatment catheter, particularly for catheters that use rotational mechanisms such as impellers or ablation tools or for over-the-wire catheters that provide instruments that can be inserted into vasculature of a patient over a guidewire. Any suitable purge fluid 125, such as saline, may be used. The described components and features cooperate to prevent bodily fluids from entering the catheter when parts of the catheter are stationary and also when mechanical parts are operating.
In certain embodiments, when the impeller 143 is inserted into vasculature of a patient, the proximal tube seal 135, the tube 119, and/or the distal tube seal 129 separate the purge fluid 125 within the porous drive shaft 111 from blood within the catheter 107 outside of the tube 119. The impeller 143 may include one or more blades 145 disposed along an impeller shaft 149 coupled to the drive shaft 111, in which the impeller shaft 149 has an impeller shaft lumen 153 therethrough and one or more through-holes 157 along a side of the impeller shaft 149 such that rotation of the impeller 143 in a liquid subjects the liquid to centrifugal force at the one or more holes 157. That is, when the impeller 143 is disposed within vasculature of a patient and the motor 113 is operated, the impeller 143 pumps blood and the purge fluid 125 rinses at least a portion of the impeller 143. In such scenario, purge fluid in the catheter 107 (e.g., that flowed in under gravity while the impeller was not operating) would be driven out through the through-holes 157 while the motor 113 operates, thereby securely preventing any bodily fluid from entering the device 101.
The purge system may have particular applicability on devices used in different bodily systems, such as the circulatory system and the lymphatic system. E.g., the purge fluid prevents blood from entering the device 101, so that if the device 101 is subsequently entered into a thoracic duct, blood is not brought into that area.
In certain depicted embodiments, the device 101 includes one or more inflatable balloons 163 disposed along the catheter 107, each in fluid communication with an inflation lumen 164 extending along the catheter 107.
In certain embodiments, the device 101 is designed as an over-the-wire device in that it can be delivered to a location in the vasculature of a patient by following a guidewire that has been navigated to the intended location. Preferably, the impeller 143 and the drive shaft 111 define or include a guidewire lumen 175 that extends through the impeller 143 and the drive shaft 111.
In some embodiments (see, e.g.,
Thus the disclosure provides a device 101 having an impeller 143 disposed at a distal portion 108 of a catheter 107 and dimensioned for insertion into vasculature of a patient, wherein when the impeller 143 is inserted into the vasculature of a patient, a purge fluid 125 purges the catheter 107 by hydrostatic pressure while the impeller 143 is not being rotated and the purge fluid 125 purges the catheter 107 by centrifugal force while the impeller 143 is being rotated.
Additionally, the disclosure provides a device 101 with an impeller 143 dimensioned for insertion into vasculature of a patient, a guidewire lumen 175 extending through the impeller 143, and a drive mechanism 130 operable to rotate the impeller 143 while the impeller 143 is in the vasculature with a guidewire 177 extending through the guidewire lumen 175. The drive mechanism 130 may include a hollow driveshaft 111 extending proximally from the impeller 143 to a motor 113. The hollow driveshaft 111 preferably extends through a catheter 107 having a proximal portion 106 and a distal portion 108, in which the impeller 143 is distal to the distal portion 108 and the motor 113 is proximal to the proximal portion 106 (see, e.g.,
References and citations to other documents, such as patents, patent applications, patent publications, journals, books, papers, web contents, have been made throughout this disclosure. All such documents are hereby incorporated herein by reference in their entirety for all purposes.
Various modifications of the invention and many further embodiments thereof, in addition to those shown and described herein, will become apparent to those skilled in the art from the full contents of this document, including references to the scientific and patent literature cited herein. The subject matter herein contains important information, exemplification, and guidance that can be adapted to the practice of this invention in its various embodiments and equivalents thereof.
This application is a national stage entry of PCT/IB2019/000139, filed Feb. 12, 2019, which claims priority to U.S. Provisional Application No. 62/629,914, filed Feb. 13, 2018, the contents of which are incorporated by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/IB2019/000139 | 2/12/2019 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2019/158996 | 8/22/2019 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3211150 | Foderick | Oct 1965 | A |
3884240 | Gilman | May 1975 | A |
3926175 | Allen et al. | Dec 1975 | A |
4714460 | Calderon | Dec 1987 | A |
4822341 | Colone | Apr 1989 | A |
4838864 | Peterson | Jun 1989 | A |
4957484 | Murtfeldt | Sep 1990 | A |
5005564 | Grundei et al. | Apr 1991 | A |
5069662 | Bodden | Dec 1991 | A |
5092844 | Schwartz et al. | Mar 1992 | A |
5097840 | Wallace et al. | Mar 1992 | A |
5366504 | Andersen et al. | Nov 1994 | A |
5391143 | Kensey | Feb 1995 | A |
5484412 | Pierpont | Jan 1996 | A |
5509897 | Twardowski et al. | Apr 1996 | A |
5554119 | Harrison et al. | Sep 1996 | A |
5558642 | Schweich, Jr. et al. | Sep 1996 | A |
5702364 | Euteneuer | Dec 1997 | A |
5716340 | Schweich, Jr. et al. | Feb 1998 | A |
5817046 | Glickman | Oct 1998 | A |
5836912 | Kusleika | Nov 1998 | A |
5893841 | Glickman | Apr 1999 | A |
5897533 | Glickman | Apr 1999 | A |
5908407 | Frazee et al. | Jun 1999 | A |
5919163 | Glickman | Jul 1999 | A |
5921913 | Siess | Jul 1999 | A |
6042569 | Finch, Jr. et al. | Mar 2000 | A |
6139517 | Macoviak et al. | Oct 2000 | A |
6152945 | Bachinski et al. | Nov 2000 | A |
6165196 | Stack et al. | Dec 2000 | A |
6179796 | Waldridge | Jan 2001 | B1 |
6183492 | Hart et al. | Feb 2001 | B1 |
6245007 | Bedingham et al. | Jun 2001 | B1 |
6248091 | Voelker | Jun 2001 | B1 |
6254563 | Macoviak et al. | Jul 2001 | B1 |
6443884 | Miyawaki | Sep 2002 | B1 |
6503224 | Forman et al. | Jan 2003 | B1 |
6524323 | Nash et al. | Feb 2003 | B1 |
6555057 | Bendera | Apr 2003 | B1 |
6616623 | Kutushov | Sep 2003 | B1 |
6635068 | Dubrul et al. | Oct 2003 | B1 |
6699231 | Sterman et al. | Mar 2004 | B1 |
6878140 | Barbut | Apr 2005 | B2 |
6936057 | Nobles | Aug 2005 | B1 |
7022097 | Glickman | Apr 2006 | B2 |
7195608 | Burnett | Mar 2007 | B2 |
7645259 | Goldman | Jan 2010 | B2 |
7766892 | Keren et al. | Aug 2010 | B2 |
7780628 | Keren et al. | Aug 2010 | B1 |
8109880 | Pranevicius et al. | Feb 2012 | B1 |
8126538 | Shuros et al. | Feb 2012 | B2 |
8216122 | Kung | Jul 2012 | B2 |
8480555 | Kung | Jul 2013 | B2 |
8535211 | Campbell | Sep 2013 | B2 |
8679057 | Fulton, III et al. | Mar 2014 | B2 |
9179921 | Morris | Nov 2015 | B1 |
9405942 | Liao et al. | Aug 2016 | B2 |
9421316 | Leeflang et al. | Aug 2016 | B2 |
9433713 | Corbett et al. | Sep 2016 | B2 |
9486566 | Siess | Nov 2016 | B2 |
9533054 | Yan et al. | Jan 2017 | B2 |
9533084 | Siess et al. | Jan 2017 | B2 |
9642991 | Eversull et al. | May 2017 | B2 |
9669142 | Spanier et al. | Jun 2017 | B2 |
9669144 | Spanier et al. | Jun 2017 | B2 |
9675739 | Tanner et al. | Jun 2017 | B2 |
9682223 | Callaghan et al. | Jun 2017 | B2 |
9750861 | Hastie et al. | Sep 2017 | B2 |
9770543 | Tanner et al. | Sep 2017 | B2 |
9878080 | Kaiser et al. | Jan 2018 | B2 |
9901722 | Nitzan et al. | Feb 2018 | B2 |
9962170 | Jansen | May 2018 | B2 |
10149684 | Nitzan et al. | Dec 2018 | B2 |
10154846 | Nitzan et al. | Dec 2018 | B2 |
10195405 | Nitzan et al. | Feb 2019 | B2 |
10207086 | Nitzan et al. | Feb 2019 | B2 |
10226604 | Nitzan et al. | Mar 2019 | B2 |
10226605 | Nitzan et al. | Mar 2019 | B2 |
10245363 | Rowe | Apr 2019 | B1 |
10285708 | Nitzan et al. | May 2019 | B2 |
10300254 | Nitzan et al. | May 2019 | B2 |
10639460 | Nitzan et al. | May 2020 | B2 |
10653871 | Nitzan et al. | May 2020 | B2 |
10709878 | Nitzan et al. | Jul 2020 | B2 |
10912873 | Nitzan et al. | Feb 2021 | B2 |
10926069 | Nitzan et al. | Feb 2021 | B2 |
10960189 | Nitzan et al. | Mar 2021 | B2 |
11007353 | Gerrans et al. | May 2021 | B2 |
11166730 | Nitzan et al. | Nov 2021 | B2 |
11179550 | Nitzan et al. | Nov 2021 | B2 |
11179551 | Nitzan et al. | Nov 2021 | B2 |
11179552 | Nitzan et al. | Nov 2021 | B2 |
11357959 | Nitzan et al. | Jun 2022 | B2 |
11406393 | Nitzan | Aug 2022 | B2 |
20020010418 | Lary et al. | Jan 2002 | A1 |
20030093109 | Mauch | May 2003 | A1 |
20030134416 | Yamanishi et al. | Jul 2003 | A1 |
20030208097 | Aboul-Hosn et al. | Nov 2003 | A1 |
20040006306 | Evans et al. | Jan 2004 | A1 |
20040064091 | Keren et al. | Apr 2004 | A1 |
20040147871 | Burnett | Jul 2004 | A1 |
20040210296 | Schmitt et al. | Oct 2004 | A1 |
20040230181 | Cawood | Nov 2004 | A1 |
20050085772 | Zafirelis et al. | Apr 2005 | A1 |
20050228474 | Laguna | Oct 2005 | A1 |
20050251180 | Burton et al. | Nov 2005 | A1 |
20060030814 | Valencia et al. | Feb 2006 | A1 |
20060064059 | Gelfand et al. | Mar 2006 | A1 |
20060100658 | Obana et al. | May 2006 | A1 |
20060161095 | Aboul-Hosn et al. | Jul 2006 | A1 |
20060178604 | Alderman | Aug 2006 | A1 |
20070055299 | Ishimaru et al. | Mar 2007 | A1 |
20070282303 | Nash et al. | Dec 2007 | A1 |
20070282382 | Shuros et al. | Dec 2007 | A1 |
20080009719 | Shuros et al. | Jan 2008 | A1 |
20080015628 | Dubrul et al. | Jan 2008 | A1 |
20080071135 | Shaknovich | Mar 2008 | A1 |
20080097412 | Shuros et al. | Apr 2008 | A1 |
20080103573 | Gerber | May 2008 | A1 |
20080140000 | Shuros et al. | Jun 2008 | A1 |
20080294228 | Brooke et al. | Nov 2008 | A1 |
20090018526 | Power et al. | Jan 2009 | A1 |
20090069829 | Shturman | Mar 2009 | A1 |
20090112184 | Fierens et al. | Apr 2009 | A1 |
20090131785 | Lee et al. | May 2009 | A1 |
20100168649 | Schwartz et al. | Jul 2010 | A1 |
20100179389 | Moroney, III et al. | Jul 2010 | A1 |
20100280451 | Teeslink et al. | Nov 2010 | A1 |
20100318114 | Pranevicius et al. | Dec 2010 | A1 |
20110004046 | Campbell et al. | Jan 2011 | A1 |
20110092955 | Purdy et al. | Apr 2011 | A1 |
20110257462 | Rodefeld et al. | Oct 2011 | A1 |
20110276023 | Leeflang et al. | Nov 2011 | A1 |
20110282274 | Fulton, III | Nov 2011 | A1 |
20110295302 | Mohl | Dec 2011 | A1 |
20120029466 | Callaghan et al. | Feb 2012 | A1 |
20120157913 | Aziz et al. | Jun 2012 | A1 |
20120178986 | Campbell et al. | Jul 2012 | A1 |
20120259215 | Gerrans et al. | Oct 2012 | A1 |
20130096476 | Rogachevsky | Apr 2013 | A1 |
20130096494 | Kassab | Apr 2013 | A1 |
20130138041 | Smisson, III et al. | May 2013 | A1 |
20130177432 | Toellner et al. | Jul 2013 | A1 |
20130237954 | Shuros et al. | Sep 2013 | A1 |
20130245607 | Eversull et al. | Sep 2013 | A1 |
20130303831 | Evans | Nov 2013 | A1 |
20130303969 | Keenan et al. | Nov 2013 | A1 |
20130317535 | Demmy | Nov 2013 | A1 |
20130331814 | Fulton, III et al. | Dec 2013 | A1 |
20130338559 | Franano et al. | Dec 2013 | A1 |
20140010686 | Tanner et al. | Jan 2014 | A1 |
20140128659 | Heuring et al. | May 2014 | A1 |
20140142616 | Smith | May 2014 | A1 |
20140155815 | Fulton, III et al. | Jun 2014 | A1 |
20140220617 | Yung et al. | Aug 2014 | A1 |
20140243790 | Callaghan et al. | Aug 2014 | A1 |
20140249386 | Caron et al. | Sep 2014 | A1 |
20140296615 | Franano | Oct 2014 | A1 |
20140303461 | Callaghan et al. | Oct 2014 | A1 |
20140336551 | Mantese et al. | Nov 2014 | A1 |
20140358036 | Holmes | Dec 2014 | A1 |
20150051634 | Kravik et al. | Feb 2015 | A1 |
20150157777 | Tuval et al. | Jun 2015 | A1 |
20150164662 | Tuval | Jun 2015 | A1 |
20150238671 | Mesallum | Aug 2015 | A1 |
20150283360 | Kelly | Oct 2015 | A1 |
20150306360 | Tischler | Oct 2015 | A1 |
20150343136 | Nitzan et al. | Dec 2015 | A1 |
20150343186 | Nitzan et al. | Dec 2015 | A1 |
20160022890 | Schwammenthal et al. | Jan 2016 | A1 |
20160045203 | Pollock | Feb 2016 | A1 |
20160051741 | Schwammenthal et al. | Feb 2016 | A1 |
20160129266 | Schmidt | May 2016 | A1 |
20160166463 | Douglas et al. | Jun 2016 | A1 |
20160169630 | Augustine et al. | Jun 2016 | A1 |
20160213826 | Tanner | Jul 2016 | A1 |
20160331378 | Nitzan et al. | Nov 2016 | A1 |
20170014563 | Khir | Jan 2017 | A1 |
20170095395 | Wennen et al. | Apr 2017 | A1 |
20170197021 | Nitzan et al. | Jul 2017 | A1 |
20170224512 | Hingston | Aug 2017 | A1 |
20170319764 | Tanner et al. | Nov 2017 | A1 |
20180012630 | Thomee et al. | Jan 2018 | A1 |
20180125499 | Nitzan et al. | May 2018 | A1 |
20180126130 | Nitzan et al. | May 2018 | A1 |
20180146968 | Nitzan et al. | May 2018 | A1 |
20180169312 | Barry | Jun 2018 | A1 |
20180185622 | Nitzan et al. | Jul 2018 | A1 |
20180193614 | Nitzan et al. | Jul 2018 | A1 |
20180193615 | Nitzan et al. | Jul 2018 | A1 |
20180193616 | Nitzan et al. | Jul 2018 | A1 |
20180250456 | Nitzan | Sep 2018 | A1 |
20180303986 | Meacham | Oct 2018 | A1 |
20190014991 | Maki et al. | Jan 2019 | A1 |
20190046706 | Aboul-Hosn et al. | Feb 2019 | A1 |
20190046707 | Aboul-Hosn et al. | Feb 2019 | A1 |
20190083761 | Nitzan et al. | Mar 2019 | A1 |
20190117943 | Nitzan et al. | Apr 2019 | A1 |
20190117944 | Nitzan et al. | Apr 2019 | A1 |
20190126014 | Kapur et al. | May 2019 | A1 |
20190167878 | Rowe | Jun 2019 | A1 |
20190223877 | Nitzan et al. | Jul 2019 | A1 |
20190366063 | Nitzan et al. | Dec 2019 | A1 |
20200016383 | Nitzan et al. | Jan 2020 | A1 |
20200030586 | Nitzan et al. | Jan 2020 | A1 |
20200030587 | Nitzan et al. | Jan 2020 | A1 |
20200046372 | Nitzan | Feb 2020 | A1 |
20200206485 | Nitzan et al. | Jul 2020 | A1 |
20200230380 | Nitzan et al. | Jul 2020 | A1 |
20200230381 | Nitzan et al. | Jul 2020 | A1 |
20200261706 | Nitzan et al. | Aug 2020 | A1 |
20200268951 | Nitzan et al. | Aug 2020 | A1 |
20200268952 | Nitzan et al. | Aug 2020 | A1 |
20200268954 | Nitzan et al. | Aug 2020 | A1 |
20200269025 | Nitzan et al. | Aug 2020 | A1 |
20200276369 | Nitzan et al. | Sep 2020 | A1 |
20200306436 | Tanner et al. | Oct 2020 | A1 |
20200397963 | Nitzan et al. | Dec 2020 | A1 |
20210121678 | Nitzan et al. | Apr 2021 | A1 |
20210378676 | Keating et al. | Dec 2021 | A1 |
20210378677 | Keating et al. | Dec 2021 | A1 |
20210378678 | Keating et al. | Dec 2021 | A1 |
20210379329 | Keating et al. | Dec 2021 | A1 |
20220039803 | Nitzan et al. | Feb 2022 | A1 |
20220104827 | Keating et al. | Apr 2022 | A1 |
20220104828 | Keating et al. | Apr 2022 | A1 |
20220218360 | Nitzan et al. | Jul 2022 | A1 |
20220218961 | Nitzan et al. | Jul 2022 | A1 |
20220280761 | Nitzan et al. | Sep 2022 | A1 |
20220280762 | Nitzan et al. | Sep 2022 | A1 |
20220331510 | Amstutz et al. | Oct 2022 | A1 |
Number | Date | Country |
---|---|---|
0526102 | Feb 1993 | EP |
2353501 | Aug 2011 | EP |
2353503 | Aug 2011 | EP |
2353632 | Aug 2011 | EP |
2497524 | Sep 2012 | EP |
2637927 | Sep 2013 | EP |
8904193 | May 1989 | WO |
2000024337 | May 2000 | WO |
01013983 | Mar 2001 | WO |
2012135834 | Oct 2012 | WO |
2013025826 | Feb 2013 | WO |
2013061281 | May 2013 | WO |
2014141284 | Sep 2014 | WO |
2015186003 | Dec 2015 | WO |
2017087556 | May 2017 | WO |
2018158636 | Sep 2018 | WO |
2018172848 | Sep 2018 | WO |
2018202776 | Nov 2018 | WO |
2019027380 | Feb 2019 | WO |
2020174285 | Sep 2020 | WO |
Entry |
---|
Bannon, 2011, Anatomic considerations for central venous cannulation, Risk Manag Healthc Policy 4:27-39. |
Moscucci, 2014, Section III Hemodynamic principles 10 Pressure measurement, 223-244 in Grossman & Baim's Cardiac Catheterization, Angiography, and Intervention 8 Ed. |
Shimizu, 2014, Embolization of a fractured central venous catheter placed using the internal jugular apporach, Int J Surg Case Rep 5:219. |
Stone, 2010, The effect of rigid cervical collars on internal jugular vein dimensions, Acad Emerg Med 17(1):100-102. |
Swan, 1970, Catheterization of the Heart in Man with Use of a Flow-directed Balloon-tipped Catheter, NEJM 283(9):447-451. |
Yancy, 2013, 2013 ACCF/AHA Guideline for the Management of Heart Failure, Circulation 128(16):e240-e327. |
Biran, 2017, Heparin coatings for improving blood compatibility of medical devices, Adv Drug Delivery Rev, 112:12-23. |
Shimizu, 2014, Embolization of a fractured central venous catheter placed using the internal jugular apporach, Int J Surg Case Rep 5:219-221. |
Webb, 2012, Roughness parameters for standard description of surface nanoarchitecture, Scanning 34:257-263. |
Blitz, 2014, Pump thrombosis—a riddle wrapped in a mystery inside an enigma, Ann Cardiothorac Surg, 3(5):450-471. |
Chikly, 2005, Manual techniques addressing the lymphatic system: origins and development, JAOA 105(10):457-464. |
Ratnayake, 2018, The Anatomy and physiology of the terminal thoracic duct and ostial valve in health and disease: potential implications for intervention, J Anat 233:1-14. |
Tchantchaleishvili, 2014, Evaluation and treatment of pump thrombosis and hemolysis, Ann Cardiothorac Surg, 3(5):490-495. |
Number | Date | Country | |
---|---|---|---|
20200397963 A1 | Dec 2020 | US |
Number | Date | Country | |
---|---|---|---|
62629914 | Feb 2018 | US |